Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2324results about "Tetrapeptide ingredients" patented technology

Bicyclic peptide ligands specific for nectin-4

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and / or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
Owner:BICYCLETX LTD

Anti-aging cubilose active peptide subjected to high-throughput screening by using molecular docking technology and application thereof

The invention provides an anti-aging cubilose active peptide obtained by high-throughput screening through a molecular docking technology and application thereof. The polypeptide comprises amino acid repetitive sequences of YY, FF, WW, AA or GG; the number of amino acid residues of the polypeptide is 3-8. The polypeptide provided by the invention is derived from cubilose and has the advantages of small molecular weight and good affinity with transporter PepT1, and a cubilose enzymolysis product containing the polypeptide provided by the invention has moderate moisture retention, capability of promoting cell synthesis FLG, capability of preventing or retarding cell UVB damage and capability of promoting cell scratch repair or animal skin wound or wound healing. The compound can be used for developing medicines, foods, health-care products or cosmetics, and has a wide application prospect.
Owner:GUANGZHOU WANYAN TRADING CO LTD +1

Preparation method of active peptide and stem cell exosome mixed hair restorer

The invention provides a preparation method of a mixed pilatory of active peptide and stem cell exosome, and belongs to the technical field of pilatory preparation. The preparation method comprises the following steps: extracting the stem cell exosome; extracting an active extract; preparing an exosome entrapped active extract; preparing the liposome loaded active peptide; preparing the liposome loaded active peptide modified by the gallic acid modified chitosan; and preparing the mixed hair restorer. The prepared mixed hair restorer can provide a suitable growth environment for hair follicles and promote hair growth, the synergistic effect of the active peptide and the exosome can provide abundant signal molecules and enhance the stimulation effect on hair follicle cells, and the active peptide and the exosome can promote angiogenesis and increase the blood flow volume of scalp, so that the hair follicle can be effectively promoted. More nutrition and oxygen are provided for hair follicles, and the growth of hair is effectively promoted.
Owner:BEIJING BOSHIYUAN HAIR RES CENT

Walnut meal-derived antibacterial polypeptide and application thereof

The invention discloses a walnut meal-derived antibacterial polypeptide and application thereof, and belongs to the technical field of biology. The amino acid sequence of the walnut meal-derived antibacterial polypeptide disclosed by the invention is shown as any one of SEQ ID NO.1-3. The walnut meal is adopted as the raw material, the antibacterial polypeptide is extracted and separated, the utilization rate of the walnut meal can be effectively increased, resource waste is reduced, a new polypeptide variety is provided for the antibacterial polypeptide field, and new resources are provided for development of novel antibacterial agents, bacterial lysis solutions, food preservatives and anti-infection drugs.
Owner:YANCHENG INST OF TECH

Preparation and application of antioxidative, anti-inflammatory and hypoglycemic lactoferrin peptide

The invention discloses preparation and application of antioxidative, anti-inflammatory and hypoglycemic lactoferrin peptide, and belongs to the field of food science and nutriology. According to the invention, lactoferrin is used as a raw material, hydrolysis is carried out by using a composite enzymatic hydrolysis method, and the molecular weight is obtained by ultrafiltration; the preparation method comprises the following steps: preparing a component of antioxidant, anti-inflammatory and hypoglycemic peptide from the active peptide YLSW (Tyr-Leu-Ser-Trp), carrying out freeze drying on the component to obtain peptide powder rich in antioxidant, anti-inflammatory and hypoglycemic peptides, identifying peptide fragments contained in the peptide powder by utilizing an LC-MS / MS technology, and screening out the active peptide YLSW (Tyr-Leu-Ser-Trp) with antioxidant, anti-inflammatory and hypoglycemic triple functions. The active peptide is added into the product to obtain the antioxidant, anti-inflammatory and hypoglycemic functional product.
Owner:NINGBO UNIV

Stem cell exosome anti-hair loss and hair growth compound and preparation method thereof

The invention relates to the technical field of biology, and discloses a stem cell exosome anti-hair loss and hair growth complex and a preparation method thereof.A hair growth agent is wrapped and loaded in adipose-derived mesenchymal stem cell exosome to form a drug-loaded stem cell exosome; the medicine-carrying stem cell exosome is loaded in cross-linked hydrogel composed of a gentisic acid-cyclodextrin complex and epsilon-polylysine modified hyaluronic acid to form the stem cell exosome anti-hair loss and hair growth complex, and the stem cell exosome anti-hair loss and hair growth complex is directly smeared and externally applied to the scalp surface and acts on the hair follicle infection part in a targeted mode, so that the hair loss prevention and hair growth promotion effect is achieved. The stem cell exosome anti-hair-loss and hair-growth-promoting compound can inhibit bacterial growth, relieve and treat hair follicle inflammation caused by bacterial infection and improve the scalp environment, so that under the condition that inflammation is effectively controlled, the drug-loaded stem cell exosome in the stem cell exosome anti-hair-loss and hair-growth-promoting compound is stably released, damaged hair follicle cells are repaired, hair regeneration is promoted, the exosome treatment effect is prolonged, and the anti-hair-loss and hair-growth-promoting effect is achieved. The purpose of treating alopecia is achieved.
Owner:BEIJING BOSHIYUAN HAIR RES CENT

Pharmaceutical composition for treating diffuse large B-cell lymphoma and application thereof

The invention discloses application of an anti-CD20 antibody drug conjugate or a drug combination thereof in preparation of a drug for treating diffuse large B-cell lymphoma. The drug combination comprises the anti-CD20 antibody drug conjugate, gemcitabine and oxaliplatin, the anti-CD20 antibody drug conjugate or the drug combination therapy containing the anti-CD20 antibody drug conjugate has a better curative effect compared with the existing clinical second-line standard therapy.
Owner:ZHEJIANG TERUISI PHARMA INC

Tetrapeptide for promoting bone growth

The invention provides a tetrapeptide for promoting bone growth, the amino acid sequence of the tetrapeptide is Glu-Pro-Gly-Phe (EPGF), the molecular weight of the tetrapeptide is 448.48 Da, the tetrapeptide can be prepared from egg yolk protein through protease enzymolysis, separation and purification and can also be obtained through chemical solid-phase synthesis, and the tetrapeptide belongs to the technical field of functional bioactive peptides. The tetrapeptide prepared by the invention can promote the growth of osteoblasts in a body and improve the secretion level of insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1) and I-type procollagen amino terminal peptide (PINP) in cells, so that the effect of promoting bone growth is achieved, and a new functional component is provided for a product for improving bone growth.
Owner:HANGZHOU KANGYUAN FOOD SCI & TECH

Targeting Trop2 antibody coupling medicine as well as preparation method and application thereof

The invention relates to a Trop2-targeting antibody coupling drug as well as a preparation method and application thereof, in particular to a nano antibody specifically bound with Trop2 or an antigen binding fragment thereof, a polypeptide construct thereof, an antibody coupling drug, a composition and medical application. The antibody coupling drug has excellent affinity to Trop2 protein, shows good targeting and inhibitory activity to Trop2 positive tumor cells, and is good in safety.
Owner:XIAMEN UNIV +1

Tetrapeptide LILP with uric acid reducing activity and application thereof

The invention discloses a tetrapeptide LILP with uric acid reducing activity and application thereof, and belongs to the technical field of biological medicine. The amino acid sequence of the tetrapeptide LILP is Leuu-Ile-Leu-Pro, and the amino acid sequence of the tetrapeptide LILP is shown in the specification. The invention discloses that the tetrapeptide LILP has uric acid reducing activity for the first time, and uric acid generation can be reduced by reducing the activity of xanthine oxidase in the liver; uric acid discharge can be increased by reducing kidney uric acid reabsorption. The invention provides a multi-target active substance for reducing uric acid, which can be applied to preparation of medicines for preventing or treating hyperuricemia or preparation of health-care foods for assisting in reducing the level of uric acid, and has a good application prospect.
Owner:HANGZHOU KANGYUAN FOOD SCI & TECH +1

An antimicrobial peptide and its preparation method and use

The present invention belongs to the field of biotechnology, and discloses an antimicrobial peptide and a preparation method and use thereof. The antimicrobial peptide of the present invention is a mixture of any one or more of the polypeptides of RcASScGAK, RcASScGAKS, TGMRcASScGAK, and TGMRcASScGAKS. The present invention also provides a method for preparing the antimicrobial peptide by heterologous co-expression of a whole enzyme and a substrate, as well as a purification process of the antimicrobial peptide, which can successfully obtain high-yield and high-purity antimicrobial peptides, the required reagents are low-priced, the operation steps are simple and easy, and it is suitable for large-scale cultivation and purification; the antimicrobial peptide prepared by the present invention has excellent antimicrobial activity, and provides a new choice for the development of antimicrobial and anti-infective drugs.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Camel blood polypeptide and application thereof in preparation of alpha-glucosidase inhibitor

The invention discloses a camel blood polypeptide and application thereof in preparation of an alpha-glucosidase inhibitor, a series of polypeptide products are separated from camel blood, and it is found that the camel blood polypeptide with the amino acid sequence being YFKI, DPPTMEL, DKPFGPDL or SEPSGTAFG has the remarkable alpha-glucosidase inhibitory activity; the compound can be applied to preparation of drugs for treating diseases caused by abnormal activity of alpha-glucosidase.
Owner:ZHEJIANG UNIV OF SCI & TECH

Wheat peptide with hypoglycemic effect as well as preparation method and application thereof

The invention discloses a wheat peptide with a hypoglycemic effect as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The invention provides a bioactive peptide LPQ or LPQF with a hypoglycemic effect, and animal model experiments prove that the bioactive peptide can effectively reduce the blood sugar level and improve related metabolic indexes, and has no obvious side effects. The invention also provides a wheat peptide rich in oligopeptide containing the peptide fragment LPQ, and animal model experiments prove that the wheat peptide has a remarkable effect in the aspect of reducing blood sugar. The invention provides a safe and effective alternative scheme for development of diabetes treatment drugs, and has good market prospects and application potential.
Owner:HANGZHOU KANGYUAN FOOD SCI & TECH +1

Sturgeon roe peptide for preventing alcoholic liver injury as well as preparation method and application of sturgeon roe peptide

The invention discloses sturgeon roe peptide for preventing alcoholic liver injury as well as a preparation method and application of the sturgeon roe peptide. The peptide sequence is ILKPTDAGTL, ALPLDPK, LGGL, VNRDL, LLGQ, VFVLN or LAGL. The preparation method specifically comprises the following steps: (1) adding deionized water into the sturgeon roes, and homogenizing; (2) adjusting the pH value, adding alkaline protease, carrying out enzymolysis, carrying out enzyme inactivation, and cooling; and (3) performing centrifugal treatment, and taking supernate to obtain the traditional Chinese medicine composition. The sturgeon roe peptide disclosed by the invention has the efficacy of preventing or treating alcoholic liver injury, and is remarkable in hangover alleviating effect, simple to prepare and low in cost.
Owner:GUIZHOU QIANSTURGEON BIOTECHNOLOGY CO LTD

Targeted drug as well as preparation method and application thereof

The invention relates to the field of nano medicines, in particular to a targeted medicine as well as a preparation method and application thereof. The invention provides a targeted drug. The targeted drug comprises a tissue-type plasminogen activator and a targeted peptide. Thrombus targeting modification is directly carried out on a thrombolytic drug rtPA which is most widely applied clinically by utilizing a chemical method, the defects of narrow treatment time window, high dosage and high bleeding risk of the rtPA are remarkably improved, the preparation process is simple and controllable, materials required for preparation are easy to obtain, the cost is low, and the application prospect is wide. The toxic effect and degradation problems of materials such as compounds are eliminated, other instruments and equipment are not needed in the treatment process, and clinical transformation application of thrombus targeted rtPA becomes possible.
Owner:THE GBA NAT INST FOR NANOTECHNOLOGY INNOVATION

Methods and compositions for detoxification of chronic exposure to toxins

The disclosure relates to methods, compositions, and combinations for detoxification in a patient comprising performing therapeutic plasma exchange (TPE) on the patient. The disclosure also relates to methods, compositions, and combinations for removing toxins in a patient as a result of chronic exposure to the toxins, comprising performing one or more TPE sessions on the patient and administering an oral composition to the patient. The methods, compositions, and combinations of the disclosure may also be used to replenish biomarkers indicative of a healthy state of the body in order to improve immune system function or patient longevity, and / or reduce oxidative stress or inflammation. The methods, compositions, and combinations of the disclosure may also be used to reduce the level of atherosclerosis, improve cognitive function, prevent early cancer development, promote immune health, and / or treat health conditions or diseases such as autoimmune diseases, cancers, Alzheimer's disease, Parkinson's disease, chronic fatigue syndromes, or fibromyalgia. Additionally, the methods, compositions, and combinations of the disclosure may comprise an intravenous supplementation, wherein each TPE session is followed by administration to the patient of an IV composition. The disclosure further relates to oral compositions and IV compositions for use in the methods, compositions, and combinations of the disclosure.
Owner:MDLIFESPAN ENTERPRISES LLC

Bicyclic peptide ligands specific for nectin-4

The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and / or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
Owner:BICYCLETX LTD

Preparation and application of whey protein source hypoglycemic peptide with GLP-1 receptor agonist activity

PendingCN120699089AMetabolism disorderTetrapeptide ingredientsEnteroendocrine cellInsulin humulin
The invention provides a hypoglycemic peptide which is prepared by taking bovine whey protein as a raw material and is stable in gastrointestinal digestion and absorption. In an in-vitro cell experiment, the peptide fragment can improve the uptake of insulin-resistant HepG2 hepatocytes and synthesize glycogen by using glucose, can promote intestinal endocrine cells NCI-H716 to secrete GLP-1, has a certain synergistic effect, and can further play the effects of promoting GLP-1 secretion and activating a GLP-1 receptor through combined use. An insulin resistance mouse model is constructed by utilizing high-fat diet, and the peptide fragment is adopted for intervention, so that the hypoglycemic peptide is further proved to have obvious effects on losing weight, reducing lipid accumulation and assisting in reducing blood fat, and meanwhile, the hypoglycemic peptide can be used for improving insulin resistance related symptoms. The milk peptide provided by the invention has gastrointestinal digestion stability and hypoglycemic activity, can be used as a functional milk base material for developing food, medicines or health care products with the effect of regulating blood sugar, and is wide in application prospect.
Owner:CHINA AGRI UNIV

Antibody-drug conjugates

The present invention provides a novel linker, a linker payload, an antibody-drug conjugate, and an antitumor drug. Specifically, the present invention provides: an antibody-drug conjugate represented by general formula (I): A-(B-L-D) a (I) [in the formula, A is an antibody residue obtained by removing, from an antibody capable of targeting tumor cells, an intra-antibody functional group involved in binding to a linker, B is a divalent group derived from the intra-antibody functional group, and c is a monovalent group derived from the linker; (In the formula, a represents an integer of 1-10, D represents an antitumor drug residue obtained by removing one hydrogen atom or one hydroxyl group from any position of an antitumor drug molecule, an analogue thereof, or a derivative thereof, L represents a linker connecting B and D, and at least one of D and L has at least one lactone group as a substituent or protecting group at any position.
Owner:UBE CORPORATION

Spirulina phycocyanin polypeptide for relieving inflammatory response as well as preparation method and application of spirulina phycocyanin polypeptide

The invention belongs to the technical field of active peptides, and particularly relates to spirulina phycocyanin polypeptide capable of relieving inflammatory response and a preparation method and application thereof.The sequence of the spirulina phycocyanin polypeptide is shown as SEQ ID NO.1, a polypeptide sequence structure is obtained through enzymolysis, separation and structural identification, and the spirulina phycocyanin polypeptide is obtained through enzymolysis, separation and structural identification. A macrophage in-vitro anti-inflammatory experiment verifies that the active peptide has anti-inflammatory ability.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES) +1

Active peptide capable of enhancing intestinal barrier function as well as preparation method and application of active peptide

The invention belongs to the technical field of protein, and relates to an active peptide for enhancing intestinal barrier function and a preparation method and application thereof, and the amino acid sequence of the peptide is LIPR. According to the active peptide, the intestinal barrier function is enhanced by promoting expression of sealing protein, closing protein and ZO-1 protein, so that toxin invasion is reduced, and intestinal health is maintained. The invention also provides a preparation method and application of the active peptide for enhancing the intestinal barrier function.
Owner:HUNAN FLORAI HEALTH TECHNOLOGY CO LTD

Bird's nest peptide for promoting fibroin and inhibiting expression of inflammatory factors

The invention provides cubilose peptide derived from cubilose and capable of promoting silk polyprotein and inhibiting expression of inflammatory factors and application of the cubilose peptide. The amino acid sequence of the peptide is as shown in at least one of SEQ ID NO: 1-5. The peptide disclosed by the invention is derived from cubilose, has the performance advantages of being small in molecular weight, promoting the expression of cell filament protein, inhibiting the expression of cell inflammatory factors and reducing the level of reactive oxygen free radicals of cells, has the biological activity of moisturizing, resisting inflammation and resisting oxidation, can be used for preparing medicines, daily chemical products, moisturizing products, anti-oxidation products or anti-inflammatory products, and is wide in application prospect.
Owner:XIAMEN YAN PALACE SEELONG BIOTECHNOLOGY CO LTD

Tetrapeptide with hypoglycemic effect and preparation and application thereof

The invention discloses tetrapeptide with a hypoglycemic effect as well as preparation and application thereof, and belongs to the technical field of biological medicines. The amino acid sequence of the tetrapeptide LLRP is Leu-Leu-Arg-Pro, and the tetrapeptide LLRP has DPP-IV inhibitory activity, can effectively reduce the blood sugar level and has no obvious side effect, so that the tetrapeptide LLRP can be applied to preparation of drugs or food for reducing blood sugar. The invention further provides polypeptide containing the peptide fragment LLRP and wheat peptide rich in the polypeptide, tetrapeptide LLRP with the effect of reducing blood sugar is generated after digestion of gastrointestinal tracts, and the tetrapeptide LLRP is applied to preparation of drugs or food for reducing blood sugar. The invention provides a new scheme and theoretical basis for treatment of diabetes, and has good market prospect and application potential.
Owner:HANGZHOU KANGYUAN FOOD SCI & TECH +1

Polypeptides and use thereof

A group of polypeptides, which can be used as a tyrosinase inhibitor. The polypeptides have the effects of inhibiting tyrosinase activity, reducing melanin secretion, resisting oxidation, skin-whitening, spot-removing, etc. The polypeptides can be widely used in antioxidant drugs and in the preparation of skin-whitening cosmetics for resisting melanogenesis and lightening spots as a new raw material, and has good application scenarios.
Owner:BEIJING IMEIK TECHNOLOGY DEVELOPMENT CO LTD

ACE inhibitory peptide, preparation method and application

The invention relates to the technical field of biology, in particular to an ACE inhibitory peptide, a preparation method and application, the ACE inhibitory peptide has the amino acid sequence of Trp-Pro-Phe (WPF) or Phe-Pro-Trp (FPW) or Phe-Gly-Trp (FGW) or Leu-Pro-Val-Pro-Ala-Phe-Asn (LPVPAFN) or Leu-Trp-Trp-Leu (LWWL), the ACE inhibitory peptide WPF, FPW, FGW, LPVPAFN and LWWL have outstanding antihypertensive activity, the IC50 values of the WPF, FPW, FGW, LPVPAFN and LWWL are 0.264 mg / mL, 0.800 mg / mL, 0.106 mg A variety of aquatic product peptide powder sources are separated and purified by an affinity ultrafiltration screening method, an ultrafiltrate component is selected for amino acid sequence identification, and a new amino acid sequence with ACE inhibitory activity is screened out; the ACE inhibitory peptides WFP, FPW, FGW, LPVPAFN and LWWL prepared by the invention have outstanding antihypertensive activity.
Owner:MEITEK TECH QINGDAO

PTK7 targeted nucleic acid aptamer coupling medicine and new application thereof

The invention provides a PTK7 targeted nucleic acid aptamer coupling drug and a new application thereof, through research, drugs are respectively coupled at the third end and the fifth end of a targeted PTK7 nucleic acid aptamer, the constructed drug is found to have obvious difference in stability and drug effect, aiming at a PTK7 target spot, the most preferable targeted nucleic acid aptamer and the most preferable drug are found, and the most suitable connexon is selected, so that the PTK7 targeted nucleic acid aptamer coupling drug can be used for preparing the PTK7 targeted nucleic acid aptamer coupling drug and the new application of the PTK7 targeted nucleic acid aptamer coupling drug. Based on a covalent coupling reaction of sulfydryl-maleimide, a PTK7 targeted aptamer coupling drug SM capable of remarkably improving the anti-tumor effect is constructed, and a new direction is provided for screening more efficient anti-tumor drugs.
Owner:HANGZHOU INSTITUTE OF MEDICAL SCIENCES CHINESE ACADEMY OF SCIENCES

Fish by-product active peptide, preparation and application

The invention discloses a fish by-product active peptide, a preparation and application, and belongs to the technical field of biological active peptides. The amino acid sequences of the fish by-product active peptide are shown as SEQ ID NO: 1 to SEQ ID NO: 3. Both the single peptide fragment and the compound peptide fragment of the fish by-product active peptide can obviously inhibit NO secretion of a lipopolysaccharide (LPS)-induced macrophage (RAW264.7) inflammation model, so that the fish by-product active peptide has a relatively good application prospect in preparation of a product with an anti-inflammatory effect; and a foundation is laid for high-added-value utilization of salmon byproducts and promotion of research, development and application of functional active peptides.
Owner:QINGDAO AGRI UNIV

Short peptide from undaria pinnatifida and application thereof

The invention discloses an oligopeptide from undaria pinnatifida and application thereof. The amino acid sequence of the oligopeptide is YRKD, and the molecular weight is 580.63 g / mol. The polypeptide is identified from undaria pinnatifida through a high performance liquid chromatography technology for the first time, and an unreported oligopeptide capable of inhibiting tyrosinase and cooperating with vitamin C to synergistically inhibit tyrosinase is screened out. The oligopeptide derived from undaria pinnatifida is synthesized by a solid phase method, has the characteristics of safety, no toxicity, good water solubility and good stability, and is combined with vitamin C to generate a synergistic effect and synergistically increase the inhibition effect on tyrosinase, so that the oligopeptide can achieve a better tyrosinase inhibition effect at a lower and more stable concentration; the use concentration of the oligopeptide can be greatly reduced, the stability is enhanced, and the oligopeptide can be widely applied to preparation of cosmetics, medicines, health-care products or food additives, and has important economic value and social significance.
Owner:GUANGZHOU TAIWEI FEED CO LTD